Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Yoshimura

Showing results (31-40 of 362) with videos related to

Pageof 37
Sort By:
Biological & Pharmaceutical Bulletin|May 31, 2001
Gas chromatography-mass spectrometric determination of activity of human placental aromatase using 16alpha-hydroxyandrostenedione as a substrateM Numazawa, A Yoshimura, M Nagaoka
Research Communications in Chemical Pathology and Pharmacology|October 1, 1983
The dissolution and bioavailability of rifampicin products in healthy subjects and tubercular patientsS Shinozawa, A Yoshimura, Y Araki
Plant Molecular Biology|September 18, 1997
Linkage map of phenotype and RFLP markers in riceA Yoshimura, O Ideta, N Iwata
Experimental Nephrology|January 1, 1996
Expression of apoptosis-related molecules in acute renal injuryA Yoshimura, T Taira, T Ideura
The Journal of Biological Chemistry|February 25, 1994
Proliferation and erythroid differentiation through the cytoplasmic domain of the erythropoietin receptorK Maruyama, K Miyata, A Yoshimura
Experimental Cell Research|September 1, 1985
Mobilization and aggregation of integral membrane proteins in erythrocytes induced by interaction with influenza virus at acidic pHA Yoshimura, S Yamashina, S Ohnishi
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1993
Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 miceA Yoshimura, H Shiku, E Nakayama
Leukemia & Lymphoma|May 16, 2000
The janus kinase inhibitor, Jab/SOCS-1, is an interferon-gamma inducible gene and determines the sensitivity to interferonsH Sakamoto, I Kinjyo, A Yoshimura
Experimental Hematology|March 29, 2001
CIS1, a cytokine-inducible SH2 protein, suppresses BCR/ABL-mediated transformation. Involvement of the ubiquitin proteasome pathwayT Tauchi, A Yoshimura, K Ohyashiki
Nature|December 13, 1990
Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicityA Yoshimura, G Longmore, H F Lodish
Pageof 37

Showing results (31-40 of 362) with videos related to

Sort By:
Pageof 37
Biological & Pharmaceutical Bulletin|May 31, 2001
Gas chromatography-mass spectrometric determination of activity of human placental aromatase using 16alpha-hydroxyandrostenedione as a substrateM Numazawa, A Yoshimura, M Nagaoka
Research Communications in Chemical Pathology and Pharmacology|October 1, 1983
The dissolution and bioavailability of rifampicin products in healthy subjects and tubercular patientsS Shinozawa, A Yoshimura, Y Araki
Plant Molecular Biology|September 18, 1997
Linkage map of phenotype and RFLP markers in riceA Yoshimura, O Ideta, N Iwata
Experimental Nephrology|January 1, 1996
Expression of apoptosis-related molecules in acute renal injuryA Yoshimura, T Taira, T Ideura
The Journal of Biological Chemistry|February 25, 1994
Proliferation and erythroid differentiation through the cytoplasmic domain of the erythropoietin receptorK Maruyama, K Miyata, A Yoshimura
Experimental Cell Research|September 1, 1985
Mobilization and aggregation of integral membrane proteins in erythrocytes induced by interaction with influenza virus at acidic pHA Yoshimura, S Yamashina, S Ohnishi
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1993
Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 miceA Yoshimura, H Shiku, E Nakayama
Leukemia & Lymphoma|May 16, 2000
The janus kinase inhibitor, Jab/SOCS-1, is an interferon-gamma inducible gene and determines the sensitivity to interferonsH Sakamoto, I Kinjyo, A Yoshimura
Experimental Hematology|March 29, 2001
CIS1, a cytokine-inducible SH2 protein, suppresses BCR/ABL-mediated transformation. Involvement of the ubiquitin proteasome pathwayT Tauchi, A Yoshimura, K Ohyashiki
Nature|December 13, 1990
Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicityA Yoshimura, G Longmore, H F Lodish
Pageof 37